ClinicalTrials.Veeva

Menu

Therapeutic Controlled Hypothermia in the Treatment of Neonates With Severe Necrotizing Enterocolitis (CoolNEC)

NHS Foundation Trust logo

NHS Foundation Trust

Status

Terminated

Conditions

Necrotizing Enterocolitis

Treatments

Procedure: Standard treatment of care at normothermia
Procedure: cooling blanket/mattress

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Hypothesis: Controlled hypothermia to 33.5C for 48 hours reduces the severity of critical illness in neonates with severe necrotizing enterocolitis.

Enrollment

13 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • weight at diagnosis > 700 grams
  • confirmed NEC (Bell's stage II or III)
  • radiological evidence of pneumatosis coli
  • systemic compromise as defined by increase in ventilation requirement and/or requiring inotopic support

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

13 participants in 2 patient groups, including a placebo group

Standard treatment of care at normothermia
Placebo Comparator group
Description:
Control group: Standard treatment of care at normothermia
Treatment:
Procedure: Standard treatment of care at normothermia
cooling blanket/mattress
Experimental group
Description:
Therapeutic controlled hypothermia (33.5C) using cooling blanket/mattress
Treatment:
Procedure: cooling blanket/mattress

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems